<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Paris, F.</dc:creator>
  <dc:creator>Gaspari, L.</dc:creator>
  <dc:creator>Mbou, F.</dc:creator>
  <dc:creator>Philibert, P.</dc:creator>
  <dc:creator>Audran, F.</dc:creator>
  <dc:creator>Morel, Y.</dc:creator>
  <dc:creator>Lauber-Biason, Anna</dc:creator>
  <dc:creator>Sultan, C..</dc:creator>
  <dc:date>2016-03-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Pubertal gynecomastia is a common condition observed in up to 65% of adolescent  males. It is usually idiopathic and tends to regress within 1–2 years. In this descriptive  cross-sectional study, we investigated 25 adolescent males with prominent (&gt;B3)  and/or persistent (&gt;2 years) pubertal gynecomastia (P/PPG) to determine whether a  hormonal/genetic defect might underline this condition. Endocrine investigation  revealed the absence of hormonal disturbance for 18 boys (72%). Three patients  presented Klinefelter syndrome and three a partial androgen insensitivity syndrome  (PAIS) as a result of p.Ala646Asp and p.Ala45Gly mutations of the androgen receptor  gene. The last patient showed a 17α-hydroxylase/17,20-lyase deficiency as a result of  a compound heterozygous mutation of the CYP17A1 gene leading to  p.Pro35Thr(P35T) and p.Arg239Stop(R239X) in the P450c17 protein. Enzymatic  activity was analyzed: the mutant protein bearing the premature stop codon R239X  showed a complete loss of 17α-hydroxylase and 17,20-lyase activity. The mutant  P35T seemed to retain 15–20% of 17α-hydroxylase and about 8–10% of 17,20-lyase  activity. This work demonstrates that P/PPG had an endocrine/genetic cause in 28%  of our cases. PAIS may be expressed only by isolated gynecomastia as well as by  17α-hydroxylase/17,20-lyase deficiency. Isolated P/PPG is not always a ‘physiological’  condition and should thus be investigated through adequate endocrine and genetic  investigations, even though larger studies are needed to better determine the real  prevalence of genetic defects in such patients.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/305055</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/305055/files/lau_emi.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1111/andr.12145</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Andrology. - 2016, vol. 4, no. 2, p. 263–269</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">adolescence</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">disorders of sex differentiation</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">sex hormones</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">steroids</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">gynecomastia</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns6="xml" ns6:lang="en">Endocrine and molecular investigations in a cohort of 25 adolescent males with prominent/persistent pubertal gynecomastia</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
